Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.
about
Tamoxifen Action in ER-Negative Breast Cancer.Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer.Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis.Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients.Evaluation of menopausal status among breast cancer patients with chemotherapy-induced amenorrhea
P2860
Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Impact of biomarker changes du ...... with residual breast cancers.
@en
Impact of biomarker changes du ...... with residual breast cancers.
@nl
type
label
Impact of biomarker changes du ...... with residual breast cancers.
@en
Impact of biomarker changes du ...... with residual breast cancers.
@nl
prefLabel
Impact of biomarker changes du ...... with residual breast cancers.
@en
Impact of biomarker changes du ...... with residual breast cancers.
@nl
P2093
P2860
P1476
Impact of biomarker changes du ...... with residual breast cancers.
@en
P2093
Arisa Nishimukai
Ayako Yanai
Keiko Murase
Masashi Takeda
Michiko Imamura
Seiichi Hirota
Takahiro Watanabe
Takashi Morimoto
Takashi Nomura
Tomoko Higuchi
P2860
P2888
P304
P356
10.1007/S10147-015-0897-1
P577
2015-09-04T00:00:00Z